An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia

BACKGROUND: Triple-negative breast cancer lacks estrogen, progesterone, and HER2 receptors and is thus not possible to treat with targeted therapies for these receptors. Therefore, a greater understanding of triple-negative breast cancer is necessary for the treatment of this cancer type. In previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Norton, Kerri-Ann, Wallace, Travis, Pandey, Niranjan B., Popel, Aleksander S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504656/
https://www.ncbi.nlm.nih.gov/pubmed/28693495
http://dx.doi.org/10.1186/s12918-017-0445-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504656/
https://www.ncbi.nlm.nih.gov/pubmed/28693495
http://dx.doi.org/10.1186/s12918-017-0445-x

Ejemplares similares